Guggenheim reiterates Buy on Johnson & Johnson, $287 target
Guggenheim reaffirmed a Buy rating on Johnson & Johnson and set a $287 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.